Last week was the Hypertension Council Scientific Sessions. I am extremely proud of two of my ex-fellows who won major awards.
David Patrick won the Goldblatt Award.
We've recently published a paper in the JCI that identifies post-translationally modified peptides that are antigens in hypertension. Thanks to all my colleagues for their hard work on this project:
Please contact me if you are interested in this post doctoral position. This is a great chance to combine clinical and basic research studying an important topic. david.g.harrison@vumc.org
We're delighted to welcome Dr Meena Madhur, as a new Associate Editor on the Clinical Science Editorial Board. #ClinSciow.ly/uCWS50Mtz2H
ALT Dr Meena Madhur, Associate Editor, Clinical Science. Dr Madhur is an Associate Professor of Medicine in the Divisions of Clinical Pharmacology & Cardiovascular Medicine and an Associate Professor in the Department of Molecular Physiology & Biophysics at Vanderbilt University.
Are you interested in a post-doctoral fellowship studying super-fascinating mechanisms of inflammation in cardiovascular diseases? If so let me know. You need to be a recent PhD graduate or have a similar degree.
Thanks to all co-authors who worked so hard to get this done. Wei Chen, Justin Van Beusecum, Liang Xiao, David Patrick, Mingfang Ao, Shilin Zhao, Marcos G. Lopez, Josh Billings, Cristina Cavinato, Alexander Caulk and Jay Humphrey.
Really enjoyed sharing our research @JohnsHopkins on how to potentially target inflammation in #salt induced #hypertension! Thanks @jenpluznick for the invite 🙏🏿
Outstanding work by David and team. Very proud of him and his group. This shows a completely new way that Netosis is initiated downstream of oxidative modifications.
ahajournals.org/doi/10.1161/…
Interesting new paper showing how soluble DPP4 enhances endothelial aging and inflammation. Provides a new link between obesity and vascular disease.